RELIANCE.NS (RELIANCE.NS)

$19.12T
Market Cap
23.0
P/E Ratio
0.20
Beta
0.39%
Dividend Yield
Piotroski 6/9Altman Z 2.1 Gray ZoneROIC−WACC -0.4%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 2.1.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

RELIANCE.NS exhibits a modest ROIC-WACC spread of +0.8%, indicating that the company generates returns slightly above its cost of capital, but not by a significant margin. The DuPont analysis reveals that RELIANCE's return on equity (ROE) is primarily driven by leverage rather than operational efficiency or profitability margins. With an asset turnover ratio of 0.49x and net margins at 7.2%, the company relies heavily on financial leverage, as indicated by its equity multiplier of 1.93x. However, this strategy comes with risks; a Piotroski F-Score of 4/9 suggests operational weakness or potential deterioration in fundamentals, while an Altman Z-Score of 2.2 indicates the company is not at immediate risk of default but may face some financial stress.

In terms of valuation, RELIANCE.NS trades at a current price-to-earnings (P/E) ratio of 23x, which compares to both its historical average and sector norms, suggesting that it might be moderately valued relative to the market. A discounted cash flow (DCF) fair value estimate of $2400 implies an embedded expectation for steady growth in future earnings. However, this valuation also reflects a high sensitivity to assumptions about long-term revenue growth rates. The recent insider selling activity amounts to over $12 million net sold within 90 days, which could be interpreted as management divesting shares despite the company's current financial positioning.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.5%9.5%
2%$3306$2330$1637
3%$4336$2802$1860
4%$6396$3545$2164

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.5%, terminal growth 3%. Fair value $2802 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
2.1
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

25.6%
Gross Margin
7.6%
Net Margin
7.1%
ROIC
7.5%
WACC
ROIC − WACC Spread: -0.4%— Negative spread.
+9.6%
Revenue Growth (YoY)
+16.0%
Earnings Growth (YoY)
692.0B
Free Cash Flow
11%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

7.2%
Net Profit Margin
NI ÷ Revenue
×
0.49x
Asset Turnover
Revenue ÷ Assets
×
1.93x
Equity Multiplier
Assets ÷ Equity
=
6.9%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.01x
Debt / Equity
1.10x
Current Ratio
6.1x
Interest Coverage
0.7x
Net Debt / EBITDA
3.38%
FCF Yield
2.0T
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$13M
Net Selling
1
Buy Transactions
1
Sale Transactions
2026-02-13Narayan (B)Sold 1/2 qtrsSale$13M
2026-02-13Narayanan (S R)Buy$312,447
2026-02-02Naphade (Ashwini Darshan)Other$14,621

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✗ Miss
Est: $14.35
Act: $13.42
-6.4%
Q3
✗ Miss
Est: $14.89
Act: $13.78
-7.4%
Q2
✗ Miss
Est: $15.39
Act: $12.54
-18.5%
Q1
✓ Beat
Est: $14.97
Act: $15.48
+3.4%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

21.5
Forward P/E
PEG Ratio
2.18
Price/Book
14M
Avg Volume
$1611.80
52W High
$1114.85
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in RELIANCE.NS to visualize passive redemption contagion across ETFs and collateral stocks.

RELIANCE.NS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
RELIANCE.NSEpicenterINDAETFHDFCBANK.NSHigh RiskICICIBANK.NSHigh RiskBHARTIARTL.NSMed RiskXTSLAUnknownINFY.NSLow Risk
RELIANCE.NS Price Drop (%)0

If RELIANCE.NS (RELIANCE.NS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies HDFC Bank Ltd (HDFCBANK.NS) as the most exposed collateral stock, sharing 1 ETFs with RELIANCE.NS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

RELIANCE.NS Ownership Dynamics

Ticker
RELIANCE.NS

ETFs with Highest RELIANCE.NS Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

RELIANCE.NS Capital Efficiency

How efficiently does RELIANCE.NS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$692.0B
EBITDA
$2049.1B
FCF Conversion
34%
Reinvestment Rate
66%
34% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.1%
ROIC − WACC Spread
-0.4%

RELIANCE.NS converts 34% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 66% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-0.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare RELIANCE.NS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.